Sign inJoin waitlistJoin the waitlist

Sarah McLaughlin

Enterprise Deputy Director, Disease Group Operations and Practice Implementation, Mayo Clinic Comprehensive Cancer Center · Mayo Clinic College of Medicine and Science

Credentials: · · ·

History

Office of Clinical Trials · Mayo Clinic College of Medicine and Science
Present
Department of Surgery · Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present

Complex General Surgical Oncology
Memorial Sloan Kettering Cancer Center
2006–2008
General Surgery
Mayo Clinic Florida Hospital
2001–2006
Univ of Missouri, Kansas City Sch of Med
1997–2001

Research

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial
JAMA · 2013 · 1,241 citations
Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements
Journal of Clinical Oncology · 2008 · First of 9 authors · 492 citations
Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors
Journal of Clinical Oncology · 2008 · First of 8 authors · 165 citations

Antonio Forte
32 papers · 25 as a fellow
Sanjay Bagaria
23 papers
Judy Boughey
21 papers · 7 as a resident
James Jakub
19 papers
Richard Gray
18 papers
Amy Degnim
10 papers
Laura Vallow
10 papers
Barbara Pockaj
9 papers
Donald Northfelt
9 papers
OM
Oscar Manrique Mogollon
9 papers
Andrea Sisti
8 papers · 3 as a resident
Matthew Goetz
8 papers